72 related articles for article (PubMed ID: 20014428)
41. Inhibition of hepatic organic anion-transporting polypeptide by RNA interference in sandwich-cultured human hepatocytes: an in vitro model to assess transporter-mediated drug-drug interactions.
Liao M; Raczynski AR; Chen M; Chuang BC; Zhu Q; Shipman R; Morrison J; Lee D; Lee FW; Balani SK; Xia CQ
Drug Metab Dispos; 2010 Sep; 38(9):1612-22. PubMed ID: 20516252
[TBL] [Abstract][Full Text] [Related]
42. Clearance Prediction of HIV Protease Inhibitors in Man: Role of Hepatic Uptake.
De Bruyn T; Stieger B; Augustijns PF; Annaert PP
J Pharm Sci; 2016 Feb; 105(2):854-863. PubMed ID: 26213315
[TBL] [Abstract][Full Text] [Related]
43. Solubility profiling of HIV protease inhibitors in human intestinal fluids.
Wuyts B; Brouwers J; Mols R; Tack J; Annaert P; Augustijns P
J Pharm Sci; 2013 Oct; 102(10):3800-7. PubMed ID: 23939880
[TBL] [Abstract][Full Text] [Related]
44. Unbound ritonavir concentrations in rat and human hepatocytes.
Keemink J; Augustijns P; Annaert P
J Pharm Sci; 2015 Jul; 104(7):2378-87. PubMed ID: 25989229
[TBL] [Abstract][Full Text] [Related]
45. Use of the intestinal bile acid transporter for the uptake of cholic acid conjugates with HIV-1 protease inhibitory activity.
Kågedahl M; Swaan PW; Redemann CT; Tang M; Craik CS; Szoka FC; Oie S
Pharm Res; 1997 Feb; 14(2):176-80. PubMed ID: 9090705
[TBL] [Abstract][Full Text] [Related]
46. Evaluating variations in bilirubin glucuronidation activity by protease inhibitors in canine and human primary hepatocytes cultured in a 3D culture system.
Omori H; Chikamoto J; Nagahara M; Hirata M; Otoi T
Toxicol In Vitro; 2023 Dec; 93():105689. PubMed ID: 37660998
[TBL] [Abstract][Full Text] [Related]
47. Intracellular 'boosting' of darunavir using known transport inhibitors in primary PBMC.
Kwan WS; Janneh O; Hartkoorn R; Chandler B; Khoo S; Back D; Owen A
Br J Clin Pharmacol; 2009 Sep; 68(3):375-80. PubMed ID: 19740394
[TBL] [Abstract][Full Text] [Related]
48. Mechanistic Modeling of Pitavastatin Disposition in Sandwich-Cultured Human Hepatocytes: A Proteomics-Informed Bottom-Up Approach.
Vildhede A; Mateus A; Khan EK; Lai Y; Karlgren M; Artursson P; Kjellsson MC
Drug Metab Dispos; 2016 Apr; 44(4):505-16. PubMed ID: 26842596
[TBL] [Abstract][Full Text] [Related]
49. Analysis of two matrix metalloproteinase inhibitors and their metabolites for induction of phospholipidosis in rat and human hepatocytes(1).
Gum RJ; Hickman D; Fagerland JA; Heindel MA; Gagne GD; Schmidt JM; Michaelides MR; Davidsen SK; Ulrich RG
Biochem Pharmacol; 2001 Dec; 62(12):1661-73. PubMed ID: 11755120
[TBL] [Abstract][Full Text] [Related]
50. Hepatocellular Disposition and Transporter Interactions with Tolvaptan and Metabolites in Sandwich-Cultured Human Hepatocytes.
Lu Y; Slizgi JR; Brouwer KR; Claire RL; Freeman KM; Pan M; Brock WJ; Brouwer KL
Drug Metab Dispos; 2016 Jun; 44(6):867-70. PubMed ID: 27013400
[TBL] [Abstract][Full Text] [Related]
51. Plasma clearance of cholyl-lysyl-fluorescein: a pilot study in humans.
Milkiewicz P; Baiocchi L; Mills CO; Ahmed M; Khalaf H; Keogh A; Baker J; Elias E
J Hepatol; 1997 Dec; 27(6):1106-9. PubMed ID: 9453437
[TBL] [Abstract][Full Text] [Related]
52. Free concentrations of intracellular fluorescent anions determined by cytoplasmic dialysis of isolated hepatocytes.
Weinman SA; Maglova LM
Am J Physiol; 1994 Nov; 267(5 Pt 1):G922-31. PubMed ID: 7977756
[TBL] [Abstract][Full Text] [Related]
53. Sandwich-Cultured Hepatocytes as a Tool to Study Drug Disposition and Drug-Induced Liver Injury.
Yang K; Guo C; Woodhead JL; St Claire RL; Watkins PB; Siler SQ; Howell BA; Brouwer KLR
J Pharm Sci; 2016 Feb; 105(2):443-459. PubMed ID: 26869411
[TBL] [Abstract][Full Text] [Related]
54. Interaction between HIV protease inhibitors (PIs) and hepatic transporters in sandwich cultured human hepatocytes: implication for PI-based DDIs.
Liu L; Unadkat JD
Biopharm Drug Dispos; 2013 Apr; 34(3):155-64. PubMed ID: 23280499
[TBL] [Abstract][Full Text] [Related]
55. Combination lopinavir and ritonavir alter exogenous and endogenous bile acid disposition in sandwich-cultured rat hepatocytes.
Griffin LM; Watkins PB; Perry CH; St Claire RL; Brouwer KL
Drug Metab Dispos; 2013 Jan; 41(1):188-96. PubMed ID: 23091188
[TBL] [Abstract][Full Text] [Related]
56. Heterogeneous accumulation of fluorescent bile acids in primary rat hepatocytes does not correlate with their homogenous expression of ntcp.
Murray JW; Thosani AJ; Wang P; Wolkoff AW
Am J Physiol Gastrointest Liver Physiol; 2011 Jul; 301(1):G60-8. PubMed ID: 21474652
[TBL] [Abstract][Full Text] [Related]
57. In vitro investigation of the hepatobiliary disposition mechanisms of the antifungal agent micafungin in humans and rats.
Yanni SB; Augustijns PF; Benjamin DK; Brouwer KL; Thakker DR; Annaert PP
Drug Metab Dispos; 2010 Oct; 38(10):1848-56. PubMed ID: 20606004
[TBL] [Abstract][Full Text] [Related]
58. Species-specific interaction of HIV protease inhibitors with accumulation of cholyl-glycylamido-fluorescein (CGamF) in sandwich-cultured hepatocytes.
Ye ZW; Van Pelt J; Camus S; Snoeys J; Augustijns P; Annaert P
J Pharm Sci; 2010 Jun; 99(6):2886-98. PubMed ID: 20014428
[TBL] [Abstract][Full Text] [Related]
59. Cellular accumulation of cholyl-glycylamido-fluorescein in sandwich-cultured rat hepatocytes: kinetic characterization, transport mechanisms, and effect of human immunodeficiency virus protease inhibitors.
Ye ZW; Augustijns P; Annaert P
Drug Metab Dispos; 2008 Jul; 36(7):1315-21. PubMed ID: 18420783
[TBL] [Abstract][Full Text] [Related]
60. Interaction of HIV protease inhibitors with OATP1B1, 1B3, and 2B1.
Annaert P; Ye ZW; Stieger B; Augustijns P
Xenobiotica; 2010 Mar; 40(3):163-76. PubMed ID: 20102298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
